Vertex Pharma - VRTX - stock price prediction, stock price target, analyst ratings from 30 analysts

Vertex Pharma has a share price target of US$ 500, revenue growth forecast of 8.7%, and profit growth estimate of 841.6% for FY25, based on top 30 analyst calls.